137-OR: Outcomes of Real-World Deployment of the Dulce Digital Texting Education Platform for Low-Income Diverse Populations with Diabetes

Introduction: Minorities are disproportionally impacted by T2D and have higher disease morbidity; however, prognosis improves with good glucose control. Dulce Digital (DD), a simple low-cost text message program with educational, motivational and glucose reminder messages delivered 2-3 times/day over 6 months has lowered HbA1c in RCTs for diverse low SES populations. Objective: Evaluate the reach and effectiveness of DD in real-world community settings. Methods: DD was offered throughout Southwest US sites serving low income, mostly Hispanic and Pacific Islander communities with T2D. Tailored feedback was provided based on blood glucose (BG) responses. Responses to BG prompts were categorized as follows: below 70; 71-130; 131-180; 181-250; and over 250; and analyzed using chi-square. Results: From Jan 2021 to Dec 2023, N=1724 participants were enrolled from 10 sites-Fig 1A. BG metrics demonstrate significant incremental improvements in time in target range (p .00001)-Fig 1B. There was enthusiastic adoption of DD by community sites with simple enrollment processes and minimal staff effort for deployment. Conclusion: DD texting program improved BG metrics, with greater time in range for low-income diverse communities. Outreach to enroll patients in community clinic settings and outreach events can be successful and serve as an enhanced approach to support DSME/S. Disclosure M. Ruiz: None. A. Philis-Tsimikas: Advisory Panel; Dexcom, Inc., Lilly Diabetes, Novo Nordisk, Sanofi, Medtronic, Bayer Inc. N. Orendain: None. O.F. Tavake-Pasi: None. K. Stavinoha: None. N.G. Romo: None. N. Evancha: None. E. Leven: None. Funding National Institutes of Health (1OT2 HL156812NCATS; UM1TR004407)